Accession 210
Title Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
Summary we investigated the activity of novel, isoform-selective PI3K inhibitors that target different isoforms of the p110-kDa subunit. Western blot and reverse phase protein array analyses consistently demonstrated that PIK-90 and PI-103 inhibited phosphorylation of Akt and S6, whereas p110delta or p110beta/p110delta inhibitors were less effective.
Journal Blood
Publish date March, 2009
Corresponding Author Burger JA
E-mail
Array Type Reverse phase protein array
Species
Raw data link No relevant experiment link!
Link to PubMed

PubMed ID:19318683